News

An AI tool that can analyse abnormalities in the shape and form of blood cells, and with greater accuracy and reliability than human experts, could change the way conditions such as leukaemia are diagnosed, finds a study co-led by a UCL academic.

Professor Sarah Tabrizi, Director of the UCL Huntington’s Disease Centre, has been awarded the British Neuroscience Association (BNA) Outstanding Contribution to Neuroscience Award for 2025, the association’s top annual prize.

The UK Dementia Trials Network, led by a UCL professor of neurology, is establishing a dedicated nationwide network of Dementia Research Nurses.

The latest Neuromuscular Diseases (NMD) Research Day took place in November 2025, bringing together clinicians, researchers, and partners to strengthen the future of NMD research.

The collaboration is tasked with gaining a better understanding of and validating the mechanisms involved in Developmental and Epileptic Encephalopathy (DEE).

A total of 17 academics from the UCL Faculty of Brain Sciences have been identified in Clarivate’s annual ‘Highly Cited Researchers List’ 2025.